Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 635

1.

Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates.

Polito M, d'Anzeo G, Conti A, Muzzonigro G.

BJU Int. 2012 Dec;110(11 Pt C):E954-7. doi: 10.1111/j.1464-410X.2012.11484.x. Epub 2012 Oct 19.

2.

Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.

Basal S, Wambi C, Acikel C, Gupta M, Badani K.

BJU Int. 2013 Apr;111(4):658-65. doi: 10.1111/j.1464-410X.2012.11487.x. Epub 2012 Nov 27.

3.

Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy.

Kimura M, Caso JR, Bañez LL, Koontz BF, Gerber L, Senocak C, Donatucci CF, Vujaskovic Z, Moul JW, Polascik TJ.

BJU Int. 2012 Dec;110(11 Pt C):E931-8. doi: 10.1111/j.1464-410X.2012.11168.x. Epub 2012 Apr 23.

4.

Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.

Cathala N, Mombet A, Sanchez-Salas R, Rozet F, Barret E, Giuliano F, Galiano M, Prapotnich D, Kazzazi A, Djavan B, Jaffe J, Cathelineau X, Vallancien G.

Can J Urol. 2012 Aug;19(4):6328-35.

PMID:
22892254
5.
6.

Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.

Kunelius P, Lukkarinen O.

Int J Impot Res. 1999 Feb;11(1):21-4.

PMID:
10098949
7.

Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy.

Yiou R, Cunin P, de la Taille A, Salomon L, Binhas M, Lingombet O, Paul M, Abbou C.

J Sex Med. 2011 Feb;8(2):575-82. doi: 10.1111/j.1743-6109.2010.02002.x. Epub 2010 Aug 30.

PMID:
20807323
8.

Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.

Raina R, Lakin MM, Agarwal A, Ausmundson S, Montague DK, Zippe CD.

Urology. 2004 Mar;63(3):532-7; discussion 538.

PMID:
15028452
9.
10.
11.

Erection hardness score for the evaluation of erectile dysfunction: further psychometric assessment in patients treated by intracavernous prostaglandins injections after radical prostatectomy.

Parisot J, Yiou R, Salomon L, de la Taille A, Lingombet O, Audureau E.

J Sex Med. 2014 Aug;11(8):2109-18. doi: 10.1111/jsm.12584. Epub 2014 May 20.

PMID:
24840184
12.

Reasons for discontinuing intracavernous injection therapy with prostaglandin E1 (alprostadil).

Lehmann K, Casella R, Blöchlinger A, Gasser TC.

Urology. 1999 Feb;53(2):397-400.

PMID:
9933062
13.

A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy.

Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, Makhlouf A, Ryndin I, Canales BK, Weiland D, Nakib N, Ramani A, Anderson JK, Monga M.

BJU Int. 2007 Oct;100(4):858-62.

15.

Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial.

Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A.

J Urol. 1997 Oct;158(4):1408-10.

PMID:
9302132
16.

Sexual quality of life in women partnered with men using intracavernous alprostadil injections after radical prostatectomy.

Yiou R, Ebrahiminia V, Mouracade P, Lingombet O, Abbou C.

J Sex Med. 2013 May;10(5):1355-62. doi: 10.1111/jsm.12109. Epub 2013 Feb 27.

PMID:
23444881
17.

A simplified pharmacologic erection program for patients with spinal cord injury.

Zaslau S, Nicolis C, Galea G, Britanico J, Vapnek JM.

J Spinal Cord Med. 1999 Winter;22(4):303-7.

PMID:
10751135
18.

The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function.

Mulhall JP, Parker M, Waters BW, Flanigan R.

BJU Int. 2010 Jan;105(1):37-41. doi: 10.1111/j.1464-410X.2009.08775.x. Epub 2009 Jul 31.

20.

Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.

Megas G, Papadopoulos G, Stathouros G, Moschonas D, Gkialas I, Ntoumas K.

BJU Int. 2013 Jul;112(2):E169-76. doi: 10.1111/j.1464-410X.2012.11561.x. Epub 2012 Dec 18.

Supplemental Content

Support Center